BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ross D, Zhou H, Siegel D. Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function. Chem Biol Interact 2011;192:145-9. [PMID: 20970411 DOI: 10.1016/j.cbi.2010.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Guo H, Yao J, Chen H, Wang J, Masakorala K, Jin Y, Richnow HH, Blake RE. Substrate interactions during biodegradation of benzene/alkylbenzene mixtures by Rhodococcus sp. ustb-1. International Biodeterioration & Biodegradation 2012;75:124-30. [DOI: 10.1016/j.ibiod.2012.04.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
2 Dewi R, Hamid ZA, Rajab NF, Shuib S, Razak SA. Genetic, epigenetic, and lineage-directed mechanisms in benzene-induced malignancies and hematotoxicity targeting hematopoietic stem cells niche. Hum Exp Toxicol. 2020;39:577-595. [PMID: 31884827 DOI: 10.1177/0960327119895570] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vredenburg G, Elias NS, Venkataraman H, Hendriks DFG, Vermeulen NPE, Commandeur JNM, Vos JC. Human NAD(P)H:quinone Oxidoreductase 1 (NQO1)-Mediated Inactivation of Reactive Quinoneimine Metabolites of Diclofenac and Mefenamic Acid. Chem Res Toxicol 2014;27:576-86. [DOI: 10.1021/tx400431k] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
4 De Palma G, Manno M. Metabolic polymorphisms and biomarkers of effect in the biomonitoring of occupational exposure to low-levels of benzene: state of the art. Toxicol Lett 2014;231:194-204. [PMID: 25447454 DOI: 10.1016/j.toxlet.2014.10.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
5 Eastmond DA, Keshava N, Sonawane B. Lymphohematopoietic cancers induced by chemicals and other agents and their implications for risk evaluation: An overview. Mutat Res Rev Mutat Res 2014;761:40-64. [PMID: 24731989 DOI: 10.1016/j.mrrev.2014.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
6 Megarity CF, Timson DJ. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity. Biosci Rep 2019;39:BSR20191874. [PMID: 31431515 DOI: 10.1042/BSR20191874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Yang P, Song X, Zeng T, Ai Q, Liu D, Zuo W, Zhang S, Xia C, He X, Chen N. IMM-H004, a coumarin derivative, attenuated brain ischemia/reperfusion injuries and subsequent inflammation in spontaneously hypertensive rats through inhibition of VCAM-1. RSC Adv 2017;7:27480-95. [DOI: 10.1039/c7ra02154b] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Fagerholm R, Sprott K, Heikkinen T, Bartkova J, Heikkilä P, Aittomäki K, Bartek J, Weaver D, Blomqvist C, Nevanlinna H. Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. Annals of Oncology 2013;24:2780-5. [DOI: 10.1093/annonc/mdt290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
9 Huynh DTN, Heo KS. Therapeutic targets for endothelial dysfunction in vascular diseases. Arch Pharm Res 2019;42:848-61. [PMID: 31420777 DOI: 10.1007/s12272-019-01180-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]